发明公开
EP2065379A1 BENZIMIDAZOLE COMPOUND HAVING GASTRIC ACID SECRETION INHIBITORY ACTIVITY
审中-公开
BENZIMIDAZOLVERBINDUNG MITMAGENSÄURE-SEKRETION VERHINDERNDERAKTIVITÄT
- 专利标题： BENZIMIDAZOLE COMPOUND HAVING GASTRIC ACID SECRETION INHIBITORY ACTIVITY
- 专利标题（中）： BENZIMIDAZOLVERBINDUNG MITMAGENSÄURE-SEKRETION VERHINDERNDERAKTIVITÄT
-
申请号： EP07829601.9申请日： 2007-10-11
-
公开(公告)号： EP2065379A1公开(公告)日： 2009-06-03
- 发明人: UEDA, Masato , IIDA, Daisuke , KIKUCHI, Sachiko , GOTODA, Masaharu
- 申请人： Eisai R&D Management Co., Ltd.
- 申请人地址： 6-10, Koishikawa 4-chome Bunkyo-ku Tokyo 112-8088 JP
- 专利权人： Eisai R&D Management Co., Ltd.
- 当前专利权人： Eisai R&D Management Co., Ltd.
- 当前专利权人地址： 6-10, Koishikawa 4-chome Bunkyo-ku Tokyo 112-8088 JP
- 代理机构： HOFFMANN EITLE
- 优先权： JP2006280285 20061013
- 国际公布： WO2008047681 20080424
- 主分类号： C07D401/12
- IPC分类号： C07D401/12 ; A61K31/4439 ; A61K31/549 ; A61P1/04 ; A61P31/04 ; A61P43/00 ; C07D405/14 ; C07D493/10 ; C07D513/14 ; C07D519/00
摘要：
The present invention provides a compound that has superior gastric acid secretion inhibitory action, ample long-lasting gastric acid secretion inhibitory action, and is able to maintain intragastric pH at a high level for an extended period of time, making it useful as a therapeutic or prophylactic agent for diseases or symptoms caused by gastric acid, as well as an active form of this compound (form to which the compound is converted in the body following administration thereof) in the form of a compound represented by general formula (1 a) (wherein R2 represents a group represented by formula (I) or the like, and R1, R3, W1 and X - are as defined in the description).
信息查询
